Table: Cosmo Bio -2023 group results

Cosmo Bio

14/02/2024 06:00

Feb 14 (Reuters)- 
          Cosmo Bio Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2023    Dec 31, 2022   Dec 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           9.34            9.55           9.80          5.00    
               (-2.2 pct)      (+3.5 pct)     (+4.9 pct)    (+3.6 pct) 
  Operating      519 mln         816 mln        390 mln      260 mln   
               (-36.3 pct)     (-22.2 pct)    (-25.0 pct)  (-43.3 pct) 
  Recurring      653 mln         790 mln        450 mln      290 mln   
               (-17.4 pct)     (-28.1 pct)    (-31.1 pct)  (-47.5 pct) 
  Net
  Net            442 mln         517 mln        310 mln      200 mln   
               (-14.4 pct)     (-29.8 pct)    (-30.0 pct)  (-44.6 pct) 
  EPS           75.97 yen       89.13 yen      53.12 yen    34.27 yen  
  Ann Div       30.00 yen       36.00 yen      30.00 yen               
  -Q2 Div       14.00 yen       16.00 yen      14.00 yen               
  -Q4 Div       16.00 yen       20.00 yen      16.00 yen               
  
  NOTE - Cosmo Bio Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T